First Functional Evidence That a Rare Germline TP53β Variant Drives Senescence-Associated Immune Suppression and Impairs Apoptosis and Cell Migration in Breast Cancer Patients

Investigators provided supporting evidence for the pathogenicity of the TP53β N340D variant highlights the importance of integrating functional genomics into PSGT to enhance medical decision-making.